乌帕替尼 1310726-60-3

Upadacitinib is a JAK1-selective inhibitor indicated for autoimmune and inflammatory diseases.
We offer Upadacitinib API with high purity and well-controlled impurity profile, suitable for generic development.
Manufactured under China GMP.
DMF under preparation.
Available for R&D, clinical, and commercial supply.

Shandong Jikun Biopharmaceutical Co., Ltd., established in 2022, has a planned floor area of 50,000 m? and is located in a provincial - level chemical industrial park in Shandong, China. Integrating the R & D, production, and domestic and foreign trade sales of medical devices, new materials, active pharmaceutical ingredients, pharmaceutical intermediates.

 It can efficiently undertake the whole - process services such as process R & D, process optimization, and product customization from the laboratory to scale - up production.

Upholding the vision of "Health and Beauty Go Hand in Hand", Shandong Jikun spares no effort to provide customers with high - value services and continuously contributes to a healthy and beautiful life.